Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40,682 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiomics Analysis Revealed Colorectal Cancer Pathogenesis.
Xu YJ, He Y, Chen C, Shi J, He M, Liu Y, Zhang Y, Liu Y, Zhang Y. Xu YJ, et al. Among authors: he y, he m. J Proteome Res. 2024 Jun 7;23(6):2100-2111. doi: 10.1021/acs.jproteome.3c00894. Epub 2024 Apr 18. J Proteome Res. 2024. PMID: 38634357
Morin, a matrix metalloproteinase 9 inhibitor, attenuates endothelial-to-mesenchymal transition in atherosclerosis by downregulating Notch-1 signaling.
He Y, Qin XX, Liu MW, Sun W. He Y, et al. J Integr Med. 2024 Nov;22(6):683-695. doi: 10.1016/j.joim.2024.11.002. Epub 2024 Nov 8. J Integr Med. 2024. PMID: 39572351 Free article.
This study underscores morin's potential utility in the development of anti-atherosclerotic medication. Please cite this article as: He Y, Qin XX, Liu MW, Sun W. Morin, a matrix metalloproteinase 9 inhibitor, attenuates endothelial-to-mesenchymal transition in ather …
This study underscores morin's potential utility in the development of anti-atherosclerotic medication. Please cite this article as: He
40,682 results
You have reached the last available page of results. Please see the User Guide for more information.